MétaCan
Menu
Back to cohort
Record W2912951049 · doi:10.1161/str.50.suppl_1.25

Abstract 25: Promoting Recovery After Stroke by Manipulating NMDA Receptor-Associated Signalling in the Early Post Stroke Phase

2019· article· en· W2912951049 on OpenAlexaff
Beatrice Ballarin, Hong Cui, Lucy Teves, Zhanxin Ji, Michael Tymianski

Bibliographic record

VenueStroke · 2019
Typearticle
Languageen
FieldNeuroscience
TopicNeurological Disease Mechanisms and Treatments
Canadian institutionsNoNO (Canada)Krembil Foundation
Fundersnot available
KeywordsMedicineStroke (engine)Stroke recoveryNeuroprotectionExcitotoxicityNMDA receptorReceptorPharmacologyInternal medicineAnesthesiaRehabilitationPhysical therapy

Abstract

fetched live from OpenAlex

Introduction: According to the World Health Organization (WHO), stroke remains a leading cause of mortality and neurological disability globally. To date, there is no effective pharmacological treatment to promote recovery from stroke. Promoting regenerative repair may improve recovery and it is known that N-methyl-D- aspartate receptors (NMDARs) play important roles in neural circuit rebuilding. Therefore, an appealing strategy to promote stroke recovery is to selectively inhibit cell death mechanisms while promoting pro-survival processes mediated by NMDARs. A promising agent for this purpose is Tat-NR2B9c (NA-1), a clinical-stage agent being tested in Phase 3 trials for acute ischemic stroke. Tat-NR2B9c promotes the activation of pro-survival signaling and is a potent neuroprotector against excitotoxicity. Here we sought to determine whether treatment with Tat-NR2B9c promotes functional recovery in rats subjected to ischemic brain damage during the subacute recovery phase. Methods: Stroke was induced by Pial Vessel Disruption (PVD) in Sprague Dawley rats. Permanent devascularisation was induced by removing all the pia and the attached blood vessels of the left motor cortex. Experimental groups were: PVD + Tat-NR2B9c (n = 12); PVD + Vehicle (n = 11); Sham + Tat-NR2B9c (n = 8); Sham + Vehicle (n = 8). Tat-NR2B9c was injected intravenously (IV) beginning 3 days after stroke and was administered daily for 7 days. A behavioral battery of tests followed, composed of neurological score, cylinder test, horizontal ladder and adhesive removal tests. Brains were stained with H&E and the infarct size was analyzed by ImageJ. Results: Repeated IV injections of Tat-NR2B9c led to a significant improvement in all motor tasks: decreased number in foot slips by 3.6-fold in horizontal ladder (P < 0.0001); improved neurological score by 4.7-fold compared to control (P < 0.0001); improved use of affected limb by 58% in cylinder test (P = 0.0006); reduced adhesive removal test time by 81% (P < 0.0001). There was no difference in infarct sizes between the groups. Conclusion: Treatment with Tat-NR2B9c post stroke improved functional outcome in rats subjected to PVD. Current studies are ongoing to assess the mechanism of action underlying the observed recovery.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.258
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueStrokeSame topicNeurological Disease Mechanisms and TreatmentsFrench-language works237,207